Metraipolis › archive › dc_ba3e668bf8ea

Elevated Circulating Ceramides 18:0 and 24:1 as a Risk Factor for Sarcopenia: In Vitro, Animal, and Clinical Evidence — Europe PMC PMID:42063335

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42063335
DOI: 10.1002/jcsm.70310
License (as archived): solo-consultazione
Archived: 2026-10-31T23:24:46.359Z
SHA-256 of the archived text: a32ca5a4a0d7314ace2bbb067e6428022fb5c9b6fd1bcee6ef44bc7fe3cf358e
Stable URL of this page: https://metraipolis.com/documento/dc_ba3e668bf8ea

How to cite

Elevated Circulating Ceramides 18:0 and 24:1 as a Risk Factor for Sarcopenia: In Vitro, Animal, and Clinical Evidence — Europe PMC PMID:42063335 — Europe PMC (en), https://europepmc.org/article/MED/42063335 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ba3e668bf8ea (Metraipolis archive dc_ba3e668bf8ea, sha256 a32ca5a4a0d7314ace2bbb067e6428022fb5c9b6fd1bcee6ef44bc7fe3cf358e)

BibTeX

@misc{dcba3e668bf8ea,
  title = {Elevated Circulating Ceramides 18:0 and 24:1 as a Risk Factor for Sarcopenia: In Vitro, Animal, and Clinical Evidence — Europe PMC PMID:42063335},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42063335},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ba3e668bf8ea; sha256 a32ca5a4a0d7314ace2bbb067e6428022fb5c9b6fd1bcee6ef44bc7fe3cf358e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42063335. Agents can read the archived copy with the MCP tool read_document.